Literature DB >> 28169426

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.

Federica Sora1, Alessandra Iurlo2, Simona Sica1, Roberto Latagliata3, Mario Annunziata4, Sara Galimberti5, Fausto Castagnetti6, Patrizia Pregno7, Nicola Sgherza8, Francesca Celesti9, Monica Bocchia10, Antonella Gozzini11, Carmen Fava12, Daniele Cattaneo2, Monica Crugnola13, Enrico Montefusco14, Endri Mauro15, Isabella Capodanno16, Massimo Breccia3.   

Abstract

Entities:  

Keywords:  Euro score; Sokal score; chronic myeloid leukaemia; thrombo-haemorrhagic risk; thrombocytosis

Mesh：

Substances：

Year:  2017        PMID： 28169426     DOI： 10.1111/bjh.14553

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.

Authors:  Prajwal Boddu; Lorenzo Falchi; Chitra Hosing; Kate Newberry; Prithviraj Bose; Srdan Verstovsek
Journal:  Leuk Res       Date:  2017-03-22       Impact factor: 3.156

2.  Compare the accuracy and precision of Coulter LH780, Mindray BC-6000 Plus, and Sysmex XN-9000 with the international reference flow cytometric method in platelet counting.

Authors:  Yi Sun; Zuojian Hu; Zhili Huang; Huaping Chen; Shanzi Qin; Zhong Jianing; Siyuan Chen; Xue Qin; Yi Ye; Chengbin Wang
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

3.  Liver cancer concurrent with chronic myelocytic leukemia and extreme thrombocytosis: a rare case report.

Authors:  Ping Han; Zhi-Qiang Han; Xia Mao; Jin Wang; Qin-Lu Li; Min Xiao; Li Meng; De-An Tian; Zhen-Ya Hong
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.